Imerslund-Gräsbeck Syndrome: A Rare Vitamin B12 Malabsorption Disorder
Author Information
Author(s): Gräsbeck Ralph
Primary Institution: Biochemistry Unit, Minerva Foundation Institute for Medical Research, Biomedicum Helsinki
Hypothesis
The study investigates the genetic and clinical characteristics of Imerslund-Gräsbeck syndrome (IGS), a rare disorder of vitamin B12 malabsorption.
Conclusion
Patients with Imerslund-Gräsbeck syndrome require lifelong vitamin B12 treatment, and while they remain healthy, proteinuria persists.
Supporting Evidence
- Vitamin B12 deficiency in IGS is responsive to parenteral therapy.
- Patients with IGS often present with megaloblastic anemia and proteinuria.
- Genetic mutations in the CUBN and AMN genes are associated with IGS.
Takeaway
Imerslund-Gräsbeck syndrome is a rare condition where kids can't absorb vitamin B12 properly, leading to health issues, but they can stay healthy with regular vitamin B12 shots.
Methodology
The study reviews clinical cases and genetic findings related to IGS, including patient demographics and treatment outcomes.
Limitations
Many cases may be misdiagnosed, and the exact prevalence is difficult to determine.
Participant Demographics
Patients primarily from Finland and Norway, with ages ranging from a few months to about fourteen years at diagnosis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website